The only FDA-approved closure device for use following cardiac ablations*
VASCADE MVP was evaluated in the AMBULATE pivotal trial. AMBULATE was a multicenter, randomized clinical trial with 204 patients randomized 1:1 to VASCADE MVP or manual compression.
Read the full JACC EP
1 As demonstrated in the AMBULATE Pivotal Trial. | * Cardiac ablations requiring two or more access sites within the same limb. See VASCADE MVP IFU 3972 Indications for Use
Cardiva Medical Announces First...
Cardiva Medical Announces $45 Million...
Call us today Toll Free: (in the U.S.) 1-866-602-6099
Need to speak with a Cardiva Representative?
Directions1615 Wyatt Drive Santa Clara, CA 95054
Email Us email@example.com